Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 774.80M | 1.10B | 1.07B | 1.11B | 1.28B | 639.44M |
Gross Profit | 423.16M | 595.86M | 570.65M | 597.67M | 639.24M | 375.74M |
EBITDA | 168.79M | 472.25M | 399.35M | 393.37M | 439.54M | 222.94M |
Net Income | -133.70M | -66.67M | 32.98M | 55.70M | 77.88M | -45.42M |
Balance Sheet | ||||||
Total Assets | 20.31B | 20.57B | 21.41B | 21.85B | 21.29B | 20.57B |
Cash, Cash Equivalents and Short-Term Investments | 2.10B | 1.33B | 1.88B | 2.02B | 2.02B | 2.26B |
Total Debt | 5.79B | 7.64B | 7.25B | 6.66B | 6.47B | 6.54B |
Total Liabilities | 8.24B | 9.23B | 9.48B | 9.24B | 9.00B | 9.04B |
Stockholders Equity | 8.09B | 7.54B | 7.99B | 8.45B | 8.23B | 7.72B |
Cash Flow | ||||||
Free Cash Flow | 24.67M | 57.15M | 153.57M | 265.54M | 168.02M | 293.35M |
Operating Cash Flow | 31.35M | 62.69M | 154.84M | 267.73M | 189.22M | 300.76M |
Investing Cash Flow | -321.82M | -544.28M | -540.08M | -218.81M | -38.40M | -553.70M |
Financing Cash Flow | -294.63M | -9.25M | 339.57M | -158.04M | -481.67M | 458.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $78.20B | 10.53 | 13.04% | 4.65% | 61.18% | 9.48% | |
76 Outperform | HK$189.68B | 6.84 | 9.66% | 9.18% | 9.97% | -19.80% | |
73 Outperform | HK$260.95B | 14.98 | 2.88% | 4.22% | 20.91% | -29.29% | |
70 Neutral | $149.07B | 8.79 | 4.15% | 4.41% | -10.21% | -40.22% | |
66 Neutral | HK$3.29B | 5.06 | 25.62% | 3.84% | -6.51% | 12.05% | |
58 Neutral | $12.52B | 5.23 | -2.71% | 5.27% | 5.88% | -56.03% | |
55 Neutral | HK$336.33M | ― | -7.70% | 4.10% | -28.23% | -854.72% |